Teva Offers Most Attractive Risk-Reward Profile, Citigroup Says By: Benzinga via Benzinga March 28, 2014 at 11:19 AM EDT Shares of Teva Pharmaceutical Industries (NYSE: TEVA) are trading higher 1.5 percent to $49.86 after Citigroup added the stock to the ... Read More >> Related Stocks: Teva Pharmaceutical Industries ADR